Abstract:Hirschsprung's disease (HSCR, colonic aganglionosis) is an oligogenic entity that usually requires mutations in RET and other interacting loci. Decreased levels of RET expression may lead to the manifestation of HSCR. We previously showed that RET transcription was decreased due to alteration of the TITF1 binding site by two HSCR-associated RET promoter single nucleotide polymorphisms (SNPs). This prompted us to investigate whether DNA alterations in TITF1 could play a role in HSCR by affecting the RET-regulatory properties of the TITF1 protein. Our initial study on 86 Chinese HSCR patients revealed a Gly322Ser amino acid substitution in the TITF1protein. In this study we have examined an additional 102 Chinese and 70 Caucasian patients, and 194 Chinese and 60 Caucasian unselected, unrelated, subjects as controls. The relevance of the DNA changes detected in TITF1 by direct sequencing were evaluated using bioinformatics, reporter and binding-assays, mouse neurosphere culture, immunohistochemistry and immunofluorescence techniques. Met3Leu and Pro48Pro were identified in 2 Caucasian patients and 1 Chinese patient, respectively. In vitro analysis showed that Met3Leu reduced the activity of the RET promoter by 100% in the presence of the wild-type or HSCR-associated RET promoter SNP alleles. The apparent binding affinity of the TITF1 mutated protein was not decreased. The Met3Leu mutation may affect the interaction of TITF1 with its protein partners. The absence of Titf1 expression in mouse gut but not in human gut suggests that the role of TITF1 in gut development differs between the two species. TITF1 mutations could contribute to HSCR by affecting RET expression through defective interactions with other transcription factors.

Aberrant High Expression of the TET1 Gene in Hirschsprung's Disease

Polymorphisms and Expression of the Wnt8a Gene in Hirschsprung'S Disease

Evaluation of the Thyroid Transcription Factor-1 Gene (TITF1) As a Hirschsprung's Disease Locus.

Aberrant high expression of NRG1 gene in Hirschsprung disease

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.

Expression of Dishevelled Gene in Hirschsprung's Disease.

Methylation analysis of EDNRB in human colon tissues of Hirschsprung’s disease

TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm

H3K36 methyltransferase SMYD2 affects cell proliferation and migration in Hirschsprung's disease by regulating METTL3

Expression Patterns of Dishevelled-2 in Different Colon Tissue Segments in Hirschsprung's Disease.

Down-Regulation Of Mecp2 In Hirschsprung'S Disease

Study of the Effect of Mir-124 and the Sox9 Target Gene in Hirschsprung'S Disease

Differential Expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung Disease.

Expression Analysis of Bmp2, Bmp5, Bmp10 in Human Colon Tissues from Hirschsprung Disease Patients

Wnt3a Gene Expression is Associated with Isolated Hirschsprung Disease Polymorphism and Disease Status

Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients

Differential Contributions of Rare and Common, Coding and Noncoding Ret Mutations to Multifactorial Hirschsprung Disease Liability

Mutation of the RET Proto-Oncogene in Hirschsprung^s Disease

[Mutation and expression of WNT8b gene and SHH gene in Hirschsprung disease]

Ret Mutational Spectrum In Hirschsprung Disease: Evaluation Of 601 Chinese Patients

Sequence Characterization of RET in 117 Chinese Hirschsprung Disease Families Identifies a Large Burden of De Novo and Parental Mosaic Mutations